Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -6-MTH parent results

Oct 26 (Reuters)-  
             Kainos Laboratories Inc  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             2.58                2.72             5.30      
                 (-5.3 pct)          (-2.1 pct)       (-3.2 pct)   
  Operating        214 mln             173 mln          410 mln    
                 (+23.7 pct)         (+24.7 pct)      (+2.1 pct)   
  Recurring        223 mln             170 mln          413 mln    
                 (+31.2 pct)         (+25.3 pct)      (+5.2 pct)   
  Net              156 mln             106 mln          280 mln    
                 (+47.6 pct)         (+19.3 pct)      (+21.6 pct)  
  EPS             35.96 yen           23.87 yen        65.57 yen   
  Ann Div                             12.50 yen        12.50 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             12.50 yen        12.50 yen   
   
  NOTE - Kainos Laboratories Inc is a manufacturer of clinical reagents for biochemical and immune serum studies.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Kainos Laboratories

See all news